Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Alendronate sandoz 70 mg price?Premarin alternative medications?Propofol api supplier?Taltz loss of exclusivity?Valtrex coating vs generic?
See the DrugPatentWatch profile for Tagrisso
“SPC” usually stands for Summary of Product Characteristics, a document used in the EU to describe a medicine’s approved prescribing information. “Tagrisso” is the brand name for osimertinib, a cancer medicine.
The most reliable place to get the current, official EU SPC text is through the European Medicines Agency (EMA) product information for Tagrisso (osimertinib). If you tell me your country (or whether you need EU/UK/US), I can help point you to the right official page or the exact document version you should use.
Tagrisso comes in multiple presentations, and the SPC can differ by formulation and strength (for example, tablet strength). If you share the strength (e.g., 40 mg, 80 mg) and whether you need the full SPC or just a specific section (indications, dosing, warnings), I can narrow it down to the correct document.
Other Questions About Tagrisso :